 | Up a level |
Studer, U; Ruehe, B; Waldegg, G; Vajtai, I; Escher, R; Aeberli, D (2012). Atypical presentation of Behçet's disease with central nervous system involvement successfully treated with infliximab. Rheumatology international, 32(5), pp. 1431-5. Berlin: Springer 10.1007/s00296-011-1915-x
Winterhalder, L; Eser, P; Widmer, J; Villiger, P M; Aeberli, D (2012). Changes in volumetric BMD of radius and tibia upon antidepressant drug administration in young depressive patients. Journal of musculoskeletal and neuronal interactions, 12(4), pp. 224-9. Nafplion (Greece): International Society of Musculoskeletal and Neuronal Interactions
Binder, R; Stolt, V; Engelberger, L; Aeberli, D; Walpoth, N; Janzen, J; Allemann, Y (2011). Morbus Behçet associated aortitis mimicking infective endocarditis. Cardiovascular medicine, 14, pp. 264-65. Basel: EMH Swiss Medical Publishers Ltd
Schmid, L; Müller, M; Treumann, T; Arnold, W; Möller, B; Aeberli, D; Villiger, P M (2009). Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis & rheumatism, 60(6), pp. 1632-4. Hoboken, N.J.: Wiley-Blackwell 10.1002/art.24577
Aeberli, D; Eser, P; Bonel, H; Caliezi, G; Varisco, PA; Moeller, B; Villiger, PM (2009). Metacarpal bone mineral density and geometry in Rheumatoid Arthritis: Performance of peripheral quantitative computed tomography.
Möller, B; Aeberli, D; Eggli, S; Fuhrer, M; Vajtai, I; Vöglin, E; Ziswiler, HR; Dahinden, CA; Villiger, PM (2009). Class-switzched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis. Arthritis research & therapy, 11(3), R62. London: BioMed Central 10.1186/ar2686
Aeberli, D; Stanga, Z; Gerber, N J (2000). [Fever of unknown origin as a sign of calcium pyrophosphate deposition disease]. Schweizerische medizinische Wochenschrift, 130(14), pp. 505-9. Basel: B. Schwabe & Co.
